Viroblock is a Geneva-based company founded in October 2005 with the goal of developing and commercializing a new generation of antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, such as human and avian influenzas, SARS virus and the AIDS virus. Given their particular antiviral mechanism, Viroblock’s products have a broad spectrum of action across virus families and do not lead to viral resistance.
View Top Employees from Viroblock SAWebsite | https://www.viroblock.com |
Revenue | $405000 |
Employees | 2 (2 on RocketReach) |
Founded | 2006 |
Address | Chemin Des Aulx 18, Plan-Les-Ouates, Plan-les-Ouates, Geneva 1228, CH |
Phone | +41 22 884 83 46 |
Technologies |
JavaScript,
HTML,
PHP
+38 more
(view full list)
|
Industry | Health, Wellness and Fitness, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Fitness, Sports, Health Care, Medical, Personal Health |
SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Viroblock SA employee's phone or email?
The Viroblock SA annual revenue was $405000 in 2023.
Peter Pfister is the Chairman of Viroblock SA.
2 people are employed at Viroblock SA.
Viroblock SA is based in Plan-les-Ouates, Geneva.
The NAICS codes for Viroblock SA are [3254, 32541, 32, 325].
The SIC codes for Viroblock SA are [2834, 28, 283].